Main Overview Paper
Carlozzi, N. E., Schilling, S. G., Lai, J. S., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., . . . Cella, D. (2016). HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD). Qual Life Res, 25(10), 2441-2455. doi:10.1007/s11136-016-1386-3
Primary Qualitative Paper
Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J Health Psychol, 18(2), 212-225. doi:10.1177/1359105312438109
Measure Development
Carlozzi, N. E., & Tulsky, D. S. (2012). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of health psychology, 18(2), 212-25. doi:10.1177/1359105312438109
Carlozzi, N. E., Downing, N. R., McCormack, M. K., Schilling, S. G., Perlmutter, J. S., Hahn, E. A., . . . Nance, M. A. (2016). New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system). Qual Life Res, 25(10), 2403-2415. doi:10.1007/s11136-016-1354-y
Carlozzi, N. E., Downing, N. R., Schilling, S. G., Lai, J. S., Goodnight, S. M., Miner, J. A., & S, A. F. (2016). The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea. Qual Life Res, 25(10), 2429-2439. doi:10.1007/s11136-016-1307-5
Carlozzi, N. E., Hahn, E. A., Frank, S. A., Perlmutter, J. S., Downing, N. D., McCormack, M. K., . . . Schilling, S. G. (2018). A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning. J Neurol, 265(1), 98-107. doi:10.1007/s00415-017-8677-7
Carlozzi, N. E., Schilling, S. G., Lai, J. S., Perlmutter, J. S., Nance, M. A., Waljee, J. F., . . . Dayalu, P. (2016). HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Qual Life Res, 25(10), 2417-2427. doi:10.1007/s11136-016-1273-y.
Measure Validation
Carlozzi, N. E., Ready, R. E., Frank, S. , Cella, D. , Hahn, E. A., Goodnight, S. M., Schilling, S. G., Boileau, N. R. and Dayalu, P. (2017). Patient‐reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro‐QoL) and Huntington's disease health‐related quality of life (HDQLIFE) physical function measures. Mov Disord., 32: 1096-1102. doi:10.1002/mds.27046
Carlozzi, N. E., Boileau, N. R., Paulsen, J. S., Perlmutter, J. S., Lai, J. S., Hahn, E. A., . . . Downing, N. R. (2019). End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life Planning. J Neurol, 266(10), 2406-2422. doi:10.1007/s00415-019-09417-7
Carlozzi, N. E., Ready, R. E., Frank, S., Cella, D., Hahn, E. A., Goodnight, S. M., . . . Dayalu, P. (2017). Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro-QoL) and Huntington's disease health-related quality of life (HDQLIFE) physical function measures. Mov Disord, 32(7), 1096-1102. doi:10.1002/mds.27046
Carlozzi, N. E., Boileau, N. R., Perlmutter, J. S., Chou, K. L., Stout, J. C., Paulsen, J. S., . . . Dayalu, P. (2018). Agreement between clinician-rated versus patient-reported outcomes in Huntington disease. J Neurol, 265(6), 1443-1453. doi:10.1007/s00415-018-8852-5
Carlozzi, N. E., Hahn, E. A., Goodnight, S. M., Kratz, A. L., Paulsen, J. S., Stout, J. C., . . . Ready, R. E. (2018). Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures. Psychol Assess, 30(4), 450-458. doi:10.1037/pas0000479
Carlozzi, N. E., Schilling, S., Kratz, A. L., Paulsen, J. S., Frank, S., & Stout, J. C. (2018). Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability? Qual Life Res. doi:10.1007/s11136-018-1912-6
Downing, N. R., Goodnight, S., Chae, S., Perlmutter, J. S., McCormack, M., Hahn, E., . . . Carlozzi, N. (2018). Factors Associated With End-of-Life Planning in Huntington Disease. Am J Hosp Palliat Care, 35(3), 440-447. doi:10.1177/1049909117708195
Fritz, N. E., Boileau, N. R., Stout, J. C., Ready, R., Perlmutter, J. S., Paulsen, J. S., . . . Carlozzi, N. E. (2018). Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease. J Neuropsychiatry Clin Neurosci, 30(3), 194-201. doi:10.1176/appi.neuropsych.17080173
Hahn, E. A., Downing, N. R., Stout, J. C., Paulsen, J. S., Ready, B., Goodnight, S., . . . Carlozzi, N. E. (2018). Understanding the need for assistance with survey completion in people with Huntington disease. Qual Life Res, 27(3), 801-810. doi:10.1007/s11136-017-1747-6
Lai, J. S., Goodnight, S., Downing, N. R., Ready, R. E., Paulsen, J. S., Kratz, A. L., . . . Carlozzi, N. E. (2018). Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures. Qual Life Res, 27(3), 811-822. doi:10.1007/s11136-017-1755-6
Thorley, E. M., Iyer, R. G., Wicks, P., Curran, C., Gandhi, S. K., Abler, V., . . . Carlozzi, N. E. (2018). Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States. Patient, 11(5), 547-559. doi:10.1007/s40271-018-0312-x
Wesson, M., Boileau, N. R., Perlmutter, J. S., Paulsen, J. S., Barton, S. K., McCormack, M. K., & Carlozzi, N. E. (2018). Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease. J Huntingtons Dis, 7(3), 239-249. doi:10.3233/jhd-180299
Carlozzi, N. E., Schilling, S. G., Boileau, N. R., Chou, K. L., Perlmutter, J. S., Frank, S., . . . Dayalu, P. (2019). How different aspects of motor dysfunction influence day-to-day function in huntington's disease. Mov Disord, 34(12), 1910-1914. doi:10.1002/mds.27866
Boileau, N. R., Paulsen, J. S., Ready, R. E., Hahn, E. A., Lai, J. S., & Carlozzi, N. E. (2020). Understanding domains that influence perceived stigma in individuals with Huntington disease. Rehabil Psychol, 65(2), 113-121. doi:10.1037/rep0000311
Carlozzi, N. E., Boileau, N. R., Chou, K. L., Ready, R. E., Cella, D., McCormack, M. K., . . . Dayalu, P. (2020). HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease. Mov Disord, 35(2), 326-336. doi:10.1002/mds.27908
Carlozzi, N. E., Boileau, N. R., Paulsen, J. S., Downing, N. R., Ready, R., Perlmutter, J. S., . . . Lai, J. S. (2020). Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD). Qual Life Res, 29(5), 1393-1403. doi:10.1007/s11136-019-02391-7
Carlozzi, N. E., Victorson, D., Sung, V., Beaumont, J. L., Cheng, W., Gorin, B., Duh, M. S., Samuelson, D., Tulsky, D., Gutierrez, S., Nowinski, C. J., Mueller, A., Shen, V., … Frank, S. (2014). HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington's Disease. Tremor and other hyperkinetic movements (New York, N.Y.), 4, 223. doi:10.7916/D8PN93NZ
Boileau, N. R., Stout, J. C., Paulsen, J. S., Cella, D., McCormack, M. K., Nance, M. A., . . . Carlozzi, N. E. (2017). Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease. J Huntingtons Dis, 6(3), 201-215. doi:10.3233/JHD-170238
Victorson, D., Carlozzi, N. E., Frank, S., Beaumont, J. L., Cheng, W., Gorin, B., . . . Sung, V. (2014). Identifying Motor, Emotional-Behavioral, and Cognitive Deficits that Comprise the Triad of HD Symptoms from Patient, Caregiver, and Provider Perspectives. Tremor Other Hyperkinet Mov (N Y), 4, 224. doi:10.7916/d8jw8bws